nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Ticagrelor—coronary artery disease	0.0653	0.146	CbGbCtD
Sibutramine—CYP3A4—Fenofibrate—coronary artery disease	0.0582	0.13	CbGbCtD
Sibutramine—CYP3A4—Gemfibrozil—coronary artery disease	0.0465	0.104	CbGbCtD
Sibutramine—CYP3A4—Clopidogrel—coronary artery disease	0.0403	0.0904	CbGbCtD
Sibutramine—CYP3A4—Eplerenone—coronary artery disease	0.0375	0.0841	CbGbCtD
Sibutramine—CYP3A4—Enalapril—coronary artery disease	0.0334	0.0749	CbGbCtD
Sibutramine—CYP3A4—Rosuvastatin—coronary artery disease	0.026	0.0583	CbGbCtD
Sibutramine—CYP3A4—Ezetimibe—coronary artery disease	0.026	0.0583	CbGbCtD
Sibutramine—CYP3A4—Simvastatin—coronary artery disease	0.0242	0.0542	CbGbCtD
Sibutramine—CYP3A4—Lovastatin—coronary artery disease	0.0236	0.053	CbGbCtD
Sibutramine—CYP3A4—Pravastatin—coronary artery disease	0.0236	0.053	CbGbCtD
Sibutramine—CYP3A4—Atorvastatin—coronary artery disease	0.0215	0.0483	CbGbCtD
Sibutramine—CYP3A4—Losartan—coronary artery disease	0.0197	0.0442	CbGbCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000163	0.00221	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000162	0.0022	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000162	0.0022	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTM1—coronary artery disease	0.000161	0.00218	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—HGF—coronary artery disease	0.000161	0.00218	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HSPA1A—coronary artery disease	0.000159	0.00215	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—HTR7—coronary artery disease	0.000158	0.00213	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000158	0.00213	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TNF—coronary artery disease	0.000158	0.00213	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000157	0.00212	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—ALDH2—coronary artery disease	0.000157	0.00212	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—AGER—coronary artery disease	0.000156	0.0021	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000154	0.00208	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000153	0.00207	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	0.000151	0.00204	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFBR2—coronary artery disease	0.000151	0.00204	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTP1—coronary artery disease	0.000151	0.00204	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—HMOX1—coronary artery disease	0.000149	0.00201	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GGT1—coronary artery disease	0.000149	0.00201	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000149	0.00201	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000145	0.00197	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000145	0.00197	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000144	0.00195	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—PLCB3—coronary artery disease	0.000144	0.00194	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	0.000143	0.00194	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000139	0.00188	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTM1—coronary artery disease	0.000139	0.00188	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—HGF—coronary artery disease	0.000139	0.00188	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000137	0.00186	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—SULT4A1—coronary artery disease	0.000137	0.00185	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—coronary artery disease	0.000137	0.00185	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000135	0.00183	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—SULT4A1—coronary artery disease	0.000135	0.00182	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARGC1A—coronary artery disease	0.000135	0.00182	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—AGER—coronary artery disease	0.000134	0.00181	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TGFBR2—coronary artery disease	0.000134	0.00181	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTP1—coronary artery disease	0.000134	0.00181	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HMOX1—coronary artery disease	0.000132	0.00178	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000131	0.00177	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000131	0.00177	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—SIRT1—coronary artery disease	0.00013	0.00176	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000129	0.00174	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000128	0.00173	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	0.000123	0.00167	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000123	0.00167	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HGF—coronary artery disease	0.000123	0.00166	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTM1—coronary artery disease	0.000123	0.00166	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	0.000122	0.00165	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000122	0.00164	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—ALDH2—coronary artery disease	0.000121	0.00163	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000119	0.0016	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—AGER—coronary artery disease	0.000119	0.0016	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000116	0.00157	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000116	0.00157	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000114	0.00154	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000114	0.00154	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000113	0.00153	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CAMK2D—coronary artery disease	0.000111	0.00149	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000108	0.00146	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000106	0.00143	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000105	0.00142	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—LEP—coronary artery disease	0.000103	0.00139	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	0.000103	0.00139	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000101	0.00136	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000101	0.00136	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000101	0.00136	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000101	0.00136	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CAT—coronary artery disease	0.0001	0.00136	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	0.0001	0.00135	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTM2—coronary artery disease	9.75e-05	0.00132	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM2—coronary artery disease	9.62e-05	0.0013	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NOS2—coronary artery disease	9.58e-05	0.00129	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—PLCB1—coronary artery disease	9.45e-05	0.00128	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	9.32e-05	0.00126	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	9.32e-05	0.00126	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HK1—coronary artery disease	9.32e-05	0.00126	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	9.25e-05	0.00125	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	9.12e-05	0.00123	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARG—coronary artery disease	8.95e-05	0.00121	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	8.94e-05	0.00121	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	8.94e-05	0.00121	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—GSK3B—coronary artery disease	8.9e-05	0.0012	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CREB1—coronary artery disease	8.83e-05	0.00119	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	8.7e-05	0.00118	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	8.66e-05	0.00117	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	8.37e-05	0.00113	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	8.25e-05	0.00112	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HK1—coronary artery disease	8.25e-05	0.00112	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCG5—coronary artery disease	8.25e-05	0.00112	CbGpPWpGaD
Sibutramine—Rash—Ezetimibe—coronary artery disease	8.21e-05	0.000171	CcSEcCtD
Sibutramine—Dermatitis—Ezetimibe—coronary artery disease	8.21e-05	0.000171	CcSEcCtD
Sibutramine—Confusional state—Ramipril—coronary artery disease	8.2e-05	0.000171	CcSEcCtD
Sibutramine—Discomfort—Timolol—coronary artery disease	8.2e-05	0.000171	CcSEcCtD
Sibutramine—Asthenia—Niacin—coronary artery disease	8.18e-05	0.00017	CcSEcCtD
Sibutramine—Headache—Ezetimibe—coronary artery disease	8.16e-05	0.00017	CcSEcCtD
Sibutramine—Malaise—Lisinopril—coronary artery disease	8.15e-05	0.00017	CcSEcCtD
Sibutramine—Anaphylactic shock—Ramipril—coronary artery disease	8.13e-05	0.000169	CcSEcCtD
Sibutramine—Oedema—Ramipril—coronary artery disease	8.13e-05	0.000169	CcSEcCtD
Sibutramine—Vertigo—Lisinopril—coronary artery disease	8.12e-05	0.000169	CcSEcCtD
Sibutramine—Dry mouth—Timolol—coronary artery disease	8.11e-05	0.000169	CcSEcCtD
Sibutramine—Constipation—Losartan—coronary artery disease	8.11e-05	0.000169	CcSEcCtD
Sibutramine—Pain—Losartan—coronary artery disease	8.11e-05	0.000169	CcSEcCtD
Sibutramine—Syncope—Lisinopril—coronary artery disease	8.11e-05	0.000169	CcSEcCtD
Sibutramine—Vomiting—Eplerenone—coronary artery disease	8.11e-05	0.000169	CcSEcCtD
Sibutramine—Feeling abnormal—Furosemide—coronary artery disease	8.1e-05	0.000169	CcSEcCtD
Sibutramine—Leukopenia—Lisinopril—coronary artery disease	8.09e-05	0.000169	CcSEcCtD
Sibutramine—Nausea—Fenofibrate—coronary artery disease	8.08e-05	0.000168	CcSEcCtD
Sibutramine—Pruritus—Niacin—coronary artery disease	8.07e-05	0.000168	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—SERPINE1—coronary artery disease	8.07e-05	0.00109	CbGpPWpGaD
Sibutramine—Asthenia—Pravastatin—coronary artery disease	8.06e-05	0.000168	CcSEcCtD
Sibutramine—Gastrointestinal pain—Furosemide—coronary artery disease	8.04e-05	0.000167	CcSEcCtD
Sibutramine—Rash—Eplerenone—coronary artery disease	8.04e-05	0.000167	CcSEcCtD
Sibutramine—Urticaria—Perindopril—coronary artery disease	8.04e-05	0.000167	CcSEcCtD
Sibutramine—Hypersensitivity—Trandolapril—coronary artery disease	8.03e-05	0.000167	CcSEcCtD
Sibutramine—Dermatitis—Eplerenone—coronary artery disease	8.03e-05	0.000167	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1B—coronary artery disease	8.03e-05	0.00108	CbGpPWpGaD
Sibutramine—Diarrhoea—Valsartan—coronary artery disease	8.03e-05	0.000167	CcSEcCtD
Sibutramine—Confusional state—Timolol—coronary artery disease	8.02e-05	0.000167	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CASP3—coronary artery disease	8.01e-05	0.00108	CbGpPWpGaD
Sibutramine—Shock—Ramipril—coronary artery disease	8e-05	0.000167	CcSEcCtD
Sibutramine—Hypersensitivity—Enalapril—coronary artery disease	8e-05	0.000167	CcSEcCtD
Sibutramine—Abdominal pain—Perindopril—coronary artery disease	8e-05	0.000167	CcSEcCtD
Sibutramine—Body temperature increased—Perindopril—coronary artery disease	8e-05	0.000167	CcSEcCtD
Sibutramine—Palpitations—Lisinopril—coronary artery disease	7.99e-05	0.000166	CcSEcCtD
Sibutramine—Diarrhoea—Olmesartan—coronary artery disease	7.99e-05	0.000166	CcSEcCtD
Sibutramine—Headache—Eplerenone—coronary artery disease	7.99e-05	0.000166	CcSEcCtD
Sibutramine—Thrombocytopenia—Ramipril—coronary artery disease	7.96e-05	0.000166	CcSEcCtD
Sibutramine—Anaphylactic shock—Timolol—coronary artery disease	7.95e-05	0.000166	CcSEcCtD
Sibutramine—Oedema—Timolol—coronary artery disease	7.95e-05	0.000166	CcSEcCtD
Sibutramine—Pruritus—Pravastatin—coronary artery disease	7.95e-05	0.000165	CcSEcCtD
Sibutramine—Loss of consciousness—Lisinopril—coronary artery disease	7.95e-05	0.000165	CcSEcCtD
Sibutramine—Nausea—Clopidogrel—coronary artery disease	7.94e-05	0.000165	CcSEcCtD
Sibutramine—Tachycardia—Ramipril—coronary artery disease	7.94e-05	0.000165	CcSEcCtD
Sibutramine—Skin disorder—Ramipril—coronary artery disease	7.9e-05	0.000165	CcSEcCtD
Sibutramine—Infection—Timolol—coronary artery disease	7.9e-05	0.000165	CcSEcCtD
Sibutramine—Vomiting—Simvastatin—coronary artery disease	7.9e-05	0.000164	CcSEcCtD
Sibutramine—Hypersensitivity—Telmisartan—coronary artery disease	7.89e-05	0.000164	CcSEcCtD
Sibutramine—Cough—Lisinopril—coronary artery disease	7.89e-05	0.000164	CcSEcCtD
Sibutramine—Nausea—Lovastatin—coronary artery disease	7.89e-05	0.000164	CcSEcCtD
Sibutramine—Hyperhidrosis—Ramipril—coronary artery disease	7.86e-05	0.000164	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GCLM—coronary artery disease	7.86e-05	0.00106	CbGpPWpGaD
Sibutramine—Rash—Simvastatin—coronary artery disease	7.83e-05	0.000163	CcSEcCtD
Sibutramine—Dermatitis—Simvastatin—coronary artery disease	7.82e-05	0.000163	CcSEcCtD
Sibutramine—Asthenia—Trandolapril—coronary artery disease	7.82e-05	0.000163	CcSEcCtD
Sibutramine—Shock—Timolol—coronary artery disease	7.82e-05	0.000163	CcSEcCtD
Sibutramine—Feeling abnormal—Losartan—coronary artery disease	7.82e-05	0.000163	CcSEcCtD
Sibutramine—Urticaria—Furosemide—coronary artery disease	7.81e-05	0.000163	CcSEcCtD
Sibutramine—Diarrhoea—Niacin—coronary artery disease	7.8e-05	0.000163	CcSEcCtD
Sibutramine—Asthenia—Enalapril—coronary artery disease	7.79e-05	0.000162	CcSEcCtD
Sibutramine—Headache—Simvastatin—coronary artery disease	7.78e-05	0.000162	CcSEcCtD
Sibutramine—Abdominal pain—Furosemide—coronary artery disease	7.77e-05	0.000162	CcSEcCtD
Sibutramine—Body temperature increased—Furosemide—coronary artery disease	7.77e-05	0.000162	CcSEcCtD
Sibutramine—Gastrointestinal pain—Losartan—coronary artery disease	7.76e-05	0.000162	CcSEcCtD
Sibutramine—Dizziness—Valsartan—coronary artery disease	7.76e-05	0.000162	CcSEcCtD
Sibutramine—Anorexia—Ramipril—coronary artery disease	7.75e-05	0.000161	CcSEcCtD
Sibutramine—Nausea—Ezetimibe—coronary artery disease	7.74e-05	0.000161	CcSEcCtD
Sibutramine—Skin disorder—Timolol—coronary artery disease	7.72e-05	0.000161	CcSEcCtD
Sibutramine—Dizziness—Olmesartan—coronary artery disease	7.72e-05	0.000161	CcSEcCtD
Sibutramine—Pruritus—Trandolapril—coronary artery disease	7.72e-05	0.000161	CcSEcCtD
Sibutramine—Myalgia—Lisinopril—coronary artery disease	7.7e-05	0.00016	CcSEcCtD
Sibutramine—Chest pain—Lisinopril—coronary artery disease	7.7e-05	0.00016	CcSEcCtD
Sibutramine—Arthralgia—Lisinopril—coronary artery disease	7.7e-05	0.00016	CcSEcCtD
Sibutramine—Hyperhidrosis—Timolol—coronary artery disease	7.69e-05	0.00016	CcSEcCtD
Sibutramine—Asthenia—Telmisartan—coronary artery disease	7.69e-05	0.00016	CcSEcCtD
Sibutramine—Pruritus—Enalapril—coronary artery disease	7.68e-05	0.00016	CcSEcCtD
Sibutramine—Diarrhoea—Pravastatin—coronary artery disease	7.68e-05	0.00016	CcSEcCtD
Sibutramine—Anxiety—Lisinopril—coronary artery disease	7.67e-05	0.00016	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	7.61e-05	0.00103	CbGpPWpGaD
Sibutramine—Discomfort—Lisinopril—coronary artery disease	7.6e-05	0.000158	CcSEcCtD
Sibutramine—Hypotension—Ramipril—coronary artery disease	7.6e-05	0.000158	CcSEcCtD
Sibutramine—Anorexia—Timolol—coronary artery disease	7.58e-05	0.000158	CcSEcCtD
Sibutramine—Pruritus—Telmisartan—coronary artery disease	7.58e-05	0.000158	CcSEcCtD
Sibutramine—Nausea—Eplerenone—coronary artery disease	7.57e-05	0.000158	CcSEcCtD
Sibutramine—Dizziness—Niacin—coronary artery disease	7.54e-05	0.000157	CcSEcCtD
Sibutramine—Urticaria—Losartan—coronary artery disease	7.54e-05	0.000157	CcSEcCtD
Sibutramine—Dry mouth—Lisinopril—coronary artery disease	7.53e-05	0.000157	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	7.51e-05	0.00102	CbGpPWpGaD
Sibutramine—Body temperature increased—Losartan—coronary artery disease	7.5e-05	0.000156	CcSEcCtD
Sibutramine—Abdominal pain—Losartan—coronary artery disease	7.5e-05	0.000156	CcSEcCtD
Sibutramine—Asthenia—Captopril—coronary artery disease	7.47e-05	0.000156	CcSEcCtD
Sibutramine—Diarrhoea—Trandolapril—coronary artery disease	7.46e-05	0.000155	CcSEcCtD
Sibutramine—Vomiting—Valsartan—coronary artery disease	7.46e-05	0.000155	CcSEcCtD
Sibutramine—Confusional state—Lisinopril—coronary artery disease	7.44e-05	0.000155	CcSEcCtD
Sibutramine—Diarrhoea—Enalapril—coronary artery disease	7.43e-05	0.000155	CcSEcCtD
Sibutramine—Hypotension—Timolol—coronary artery disease	7.43e-05	0.000155	CcSEcCtD
Sibutramine—Dizziness—Pravastatin—coronary artery disease	7.43e-05	0.000155	CcSEcCtD
Sibutramine—Vomiting—Olmesartan—coronary artery disease	7.42e-05	0.000155	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Ramipril—coronary artery disease	7.41e-05	0.000154	CcSEcCtD
Sibutramine—Rash—Valsartan—coronary artery disease	7.4e-05	0.000154	CcSEcCtD
Sibutramine—Dermatitis—Valsartan—coronary artery disease	7.39e-05	0.000154	CcSEcCtD
Sibutramine—Nausea—Simvastatin—coronary artery disease	7.38e-05	0.000154	CcSEcCtD
Sibutramine—Anaphylactic shock—Lisinopril—coronary artery disease	7.38e-05	0.000154	CcSEcCtD
Sibutramine—Oedema—Lisinopril—coronary artery disease	7.38e-05	0.000154	CcSEcCtD
Sibutramine—Pruritus—Captopril—coronary artery disease	7.37e-05	0.000154	CcSEcCtD
Sibutramine—Rash—Olmesartan—coronary artery disease	7.36e-05	0.000153	CcSEcCtD
Sibutramine—Insomnia—Ramipril—coronary artery disease	7.36e-05	0.000153	CcSEcCtD
Sibutramine—Dermatitis—Olmesartan—coronary artery disease	7.35e-05	0.000153	CcSEcCtD
Sibutramine—Headache—Valsartan—coronary artery disease	7.35e-05	0.000153	CcSEcCtD
Sibutramine—Diarrhoea—Telmisartan—coronary artery disease	7.33e-05	0.000153	CcSEcCtD
Sibutramine—Infection—Lisinopril—coronary artery disease	7.33e-05	0.000153	CcSEcCtD
Sibutramine—Headache—Olmesartan—coronary artery disease	7.31e-05	0.000152	CcSEcCtD
Sibutramine—Paraesthesia—Ramipril—coronary artery disease	7.3e-05	0.000152	CcSEcCtD
Sibutramine—Shock—Lisinopril—coronary artery disease	7.26e-05	0.000151	CcSEcCtD
Sibutramine—Asthenia—Perindopril—coronary artery disease	7.26e-05	0.000151	CcSEcCtD
Sibutramine—Dyspnoea—Ramipril—coronary artery disease	7.25e-05	0.000151	CcSEcCtD
Sibutramine—Vomiting—Niacin—coronary artery disease	7.25e-05	0.000151	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Timolol—coronary artery disease	7.25e-05	0.000151	CcSEcCtD
Sibutramine—Hypersensitivity—Furosemide—coronary artery disease	7.24e-05	0.000151	CcSEcCtD
Sibutramine—Somnolence—Ramipril—coronary artery disease	7.23e-05	0.000151	CcSEcCtD
Sibutramine—Thrombocytopenia—Lisinopril—coronary artery disease	7.22e-05	0.00015	CcSEcCtD
Sibutramine—Dizziness—Trandolapril—coronary artery disease	7.21e-05	0.00015	CcSEcCtD
Sibutramine—Tachycardia—Lisinopril—coronary artery disease	7.2e-05	0.00015	CcSEcCtD
Sibutramine—Insomnia—Timolol—coronary artery disease	7.19e-05	0.00015	CcSEcCtD
Sibutramine—Rash—Niacin—coronary artery disease	7.19e-05	0.00015	CcSEcCtD
Sibutramine—Dermatitis—Niacin—coronary artery disease	7.18e-05	0.00015	CcSEcCtD
Sibutramine—Dizziness—Enalapril—coronary artery disease	7.18e-05	0.00015	CcSEcCtD
Sibutramine—Skin disorder—Lisinopril—coronary artery disease	7.17e-05	0.000149	CcSEcCtD
Sibutramine—Dyspepsia—Ramipril—coronary artery disease	7.16e-05	0.000149	CcSEcCtD
Sibutramine—Pruritus—Perindopril—coronary artery disease	7.16e-05	0.000149	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	7.15e-05	0.000966	CbGpPWpGaD
Sibutramine—Headache—Niacin—coronary artery disease	7.15e-05	0.000149	CcSEcCtD
Sibutramine—Paraesthesia—Timolol—coronary artery disease	7.14e-05	0.000149	CcSEcCtD
Sibutramine—Vomiting—Pravastatin—coronary artery disease	7.14e-05	0.000149	CcSEcCtD
Sibutramine—Hyperhidrosis—Lisinopril—coronary artery disease	7.13e-05	0.000149	CcSEcCtD
Sibutramine—Diarrhoea—Captopril—coronary artery disease	7.13e-05	0.000148	CcSEcCtD
Sibutramine—Dyspnoea—Timolol—coronary artery disease	7.09e-05	0.000148	CcSEcCtD
Sibutramine—Dizziness—Telmisartan—coronary artery disease	7.08e-05	0.000148	CcSEcCtD
Sibutramine—Rash—Pravastatin—coronary artery disease	7.08e-05	0.000147	CcSEcCtD
Sibutramine—Dermatitis—Pravastatin—coronary artery disease	7.07e-05	0.000147	CcSEcCtD
Sibutramine—Decreased appetite—Ramipril—coronary artery disease	7.07e-05	0.000147	CcSEcCtD
Sibutramine—Somnolence—Timolol—coronary artery disease	7.07e-05	0.000147	CcSEcCtD
Sibutramine—Asthenia—Furosemide—coronary artery disease	7.05e-05	0.000147	CcSEcCtD
Sibutramine—Headache—Pravastatin—coronary artery disease	7.04e-05	0.000147	CcSEcCtD
Sibutramine—Anorexia—Lisinopril—coronary artery disease	7.03e-05	0.000146	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Ramipril—coronary artery disease	7.02e-05	0.000146	CcSEcCtD
Sibutramine—Dyspepsia—Timolol—coronary artery disease	7e-05	0.000146	CcSEcCtD
Sibutramine—Hypersensitivity—Losartan—coronary artery disease	6.99e-05	0.000146	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	6.98e-05	0.000943	CbGpPWpGaD
Sibutramine—Nausea—Valsartan—coronary artery disease	6.97e-05	0.000145	CcSEcCtD
Sibutramine—Pruritus—Furosemide—coronary artery disease	6.96e-05	0.000145	CcSEcCtD
Sibutramine—Constipation—Ramipril—coronary artery disease	6.96e-05	0.000145	CcSEcCtD
Sibutramine—Nausea—Olmesartan—coronary artery disease	6.93e-05	0.000144	CcSEcCtD
Sibutramine—Vomiting—Trandolapril—coronary artery disease	6.93e-05	0.000144	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	6.92e-05	0.000936	CbGpPWpGaD
Sibutramine—Diarrhoea—Perindopril—coronary artery disease	6.92e-05	0.000144	CcSEcCtD
Sibutramine—Decreased appetite—Timolol—coronary artery disease	6.91e-05	0.000144	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	6.91e-05	0.000934	CbGpPWpGaD
Sibutramine—Vomiting—Enalapril—coronary artery disease	6.91e-05	0.000144	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—CETP—coronary artery disease	6.9e-05	0.000932	CbGpPWpGaD
Sibutramine—Hypotension—Lisinopril—coronary artery disease	6.89e-05	0.000144	CcSEcCtD
Sibutramine—Dizziness—Captopril—coronary artery disease	6.89e-05	0.000143	CcSEcCtD
Sibutramine—Rash—Trandolapril—coronary artery disease	6.88e-05	0.000143	CcSEcCtD
Sibutramine—Dermatitis—Trandolapril—coronary artery disease	6.87e-05	0.000143	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Timolol—coronary artery disease	6.87e-05	0.000143	CcSEcCtD
Sibutramine—Rash—Enalapril—coronary artery disease	6.85e-05	0.000143	CcSEcCtD
Sibutramine—Dermatitis—Enalapril—coronary artery disease	6.84e-05	0.000143	CcSEcCtD
Sibutramine—Headache—Trandolapril—coronary artery disease	6.83e-05	0.000142	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	6.83e-05	0.000923	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	6.83e-05	0.000923	CbGpPWpGaD
Sibutramine—Vomiting—Telmisartan—coronary artery disease	6.81e-05	0.000142	CcSEcCtD
Sibutramine—Asthenia—Losartan—coronary artery disease	6.81e-05	0.000142	CcSEcCtD
Sibutramine—Headache—Enalapril—coronary artery disease	6.8e-05	0.000142	CcSEcCtD
Sibutramine—Pain—Timolol—coronary artery disease	6.8e-05	0.000142	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	6.8e-05	0.000919	CbGpPWpGaD
Sibutramine—Nausea—Niacin—coronary artery disease	6.77e-05	0.000141	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	6.76e-05	0.000914	CbGpPWpGaD
Sibutramine—Rash—Telmisartan—coronary artery disease	6.75e-05	0.000141	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CREB1—coronary artery disease	6.75e-05	0.000913	CbGpPWpGaD
Sibutramine—Dermatitis—Telmisartan—coronary artery disease	6.75e-05	0.000141	CcSEcCtD
Sibutramine—Diarrhoea—Furosemide—coronary artery disease	6.73e-05	0.00014	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.72e-05	0.00014	CcSEcCtD
Sibutramine—Pruritus—Losartan—coronary artery disease	6.71e-05	0.00014	CcSEcCtD
Sibutramine—Headache—Telmisartan—coronary artery disease	6.71e-05	0.00014	CcSEcCtD
Sibutramine—Feeling abnormal—Ramipril—coronary artery disease	6.7e-05	0.00014	CcSEcCtD
Sibutramine—Dizziness—Perindopril—coronary artery disease	6.69e-05	0.000139	CcSEcCtD
Sibutramine—Insomnia—Lisinopril—coronary artery disease	6.67e-05	0.000139	CcSEcCtD
Sibutramine—Nausea—Pravastatin—coronary artery disease	6.67e-05	0.000139	CcSEcCtD
Sibutramine—Gastrointestinal pain—Ramipril—coronary artery disease	6.65e-05	0.000139	CcSEcCtD
Sibutramine—Paraesthesia—Lisinopril—coronary artery disease	6.62e-05	0.000138	CcSEcCtD
Sibutramine—Vomiting—Captopril—coronary artery disease	6.62e-05	0.000138	CcSEcCtD
Sibutramine—Dyspnoea—Lisinopril—coronary artery disease	6.58e-05	0.000137	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—TGFB1—coronary artery disease	6.58e-05	0.000889	CbGpPWpGaD
Sibutramine—Rash—Captopril—coronary artery disease	6.57e-05	0.000137	CcSEcCtD
Sibutramine—Dermatitis—Captopril—coronary artery disease	6.56e-05	0.000137	CcSEcCtD
Sibutramine—Somnolence—Lisinopril—coronary artery disease	6.56e-05	0.000137	CcSEcCtD
Sibutramine—Feeling abnormal—Timolol—coronary artery disease	6.55e-05	0.000136	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TFRC—coronary artery disease	6.54e-05	0.000884	CbGpPWpGaD
Sibutramine—Headache—Captopril—coronary artery disease	6.53e-05	0.000136	CcSEcCtD
Sibutramine—Gastrointestinal pain—Timolol—coronary artery disease	6.5e-05	0.000135	CcSEcCtD
Sibutramine—Dizziness—Furosemide—coronary artery disease	6.5e-05	0.000135	CcSEcCtD
Sibutramine—Dyspepsia—Lisinopril—coronary artery disease	6.49e-05	0.000135	CcSEcCtD
Sibutramine—Diarrhoea—Losartan—coronary artery disease	6.49e-05	0.000135	CcSEcCtD
Sibutramine—Nausea—Trandolapril—coronary artery disease	6.48e-05	0.000135	CcSEcCtD
Sibutramine—Urticaria—Ramipril—coronary artery disease	6.46e-05	0.000135	CcSEcCtD
Sibutramine—Nausea—Enalapril—coronary artery disease	6.45e-05	0.000134	CcSEcCtD
Sibutramine—Vomiting—Perindopril—coronary artery disease	6.43e-05	0.000134	CcSEcCtD
Sibutramine—Body temperature increased—Ramipril—coronary artery disease	6.43e-05	0.000134	CcSEcCtD
Sibutramine—Abdominal pain—Ramipril—coronary artery disease	6.43e-05	0.000134	CcSEcCtD
Sibutramine—Decreased appetite—Lisinopril—coronary artery disease	6.41e-05	0.000134	CcSEcCtD
Sibutramine—Rash—Perindopril—coronary artery disease	6.38e-05	0.000133	CcSEcCtD
Sibutramine—Dermatitis—Perindopril—coronary artery disease	6.37e-05	0.000133	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.37e-05	0.000133	CcSEcCtD
Sibutramine—Nausea—Telmisartan—coronary artery disease	6.36e-05	0.000133	CcSEcCtD
Sibutramine—Headache—Perindopril—coronary artery disease	6.34e-05	0.000132	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	6.33e-05	0.000856	CbGpPWpGaD
Sibutramine—Urticaria—Timolol—coronary artery disease	6.32e-05	0.000132	CcSEcCtD
Sibutramine—Pain—Lisinopril—coronary artery disease	6.31e-05	0.000131	CcSEcCtD
Sibutramine—Constipation—Lisinopril—coronary artery disease	6.31e-05	0.000131	CcSEcCtD
Sibutramine—Body temperature increased—Timolol—coronary artery disease	6.29e-05	0.000131	CcSEcCtD
Sibutramine—Abdominal pain—Timolol—coronary artery disease	6.29e-05	0.000131	CcSEcCtD
Sibutramine—Dizziness—Losartan—coronary artery disease	6.27e-05	0.000131	CcSEcCtD
Sibutramine—Vomiting—Furosemide—coronary artery disease	6.25e-05	0.00013	CcSEcCtD
Sibutramine—Rash—Furosemide—coronary artery disease	6.2e-05	0.000129	CcSEcCtD
Sibutramine—Dermatitis—Furosemide—coronary artery disease	6.19e-05	0.000129	CcSEcCtD
Sibutramine—Nausea—Captopril—coronary artery disease	6.19e-05	0.000129	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	6.18e-05	0.000835	CbGpPWpGaD
Sibutramine—Headache—Furosemide—coronary artery disease	6.16e-05	0.000128	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CETP—coronary artery disease	6.11e-05	0.000826	CbGpPWpGaD
Sibutramine—Feeling abnormal—Lisinopril—coronary artery disease	6.08e-05	0.000127	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PLAT—coronary artery disease	6.08e-05	0.000821	CbGpPWpGaD
Sibutramine—Gastrointestinal pain—Lisinopril—coronary artery disease	6.03e-05	0.000126	CcSEcCtD
Sibutramine—Vomiting—Losartan—coronary artery disease	6.03e-05	0.000126	CcSEcCtD
Sibutramine—Nausea—Perindopril—coronary artery disease	6.01e-05	0.000125	CcSEcCtD
Sibutramine—Hypersensitivity—Ramipril—coronary artery disease	5.99e-05	0.000125	CcSEcCtD
Sibutramine—Rash—Losartan—coronary artery disease	5.98e-05	0.000125	CcSEcCtD
Sibutramine—Dermatitis—Losartan—coronary artery disease	5.98e-05	0.000124	CcSEcCtD
Sibutramine—Headache—Losartan—coronary artery disease	5.94e-05	0.000124	CcSEcCtD
Sibutramine—Urticaria—Lisinopril—coronary artery disease	5.86e-05	0.000122	CcSEcCtD
Sibutramine—Hypersensitivity—Timolol—coronary artery disease	5.86e-05	0.000122	CcSEcCtD
Sibutramine—Nausea—Furosemide—coronary artery disease	5.84e-05	0.000122	CcSEcCtD
Sibutramine—Asthenia—Ramipril—coronary artery disease	5.84e-05	0.000122	CcSEcCtD
Sibutramine—Body temperature increased—Lisinopril—coronary artery disease	5.83e-05	0.000121	CcSEcCtD
Sibutramine—Abdominal pain—Lisinopril—coronary artery disease	5.83e-05	0.000121	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—coronary artery disease	5.82e-05	0.000787	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.79e-05	0.000783	CbGpPWpGaD
Sibutramine—Pruritus—Ramipril—coronary artery disease	5.76e-05	0.00012	CcSEcCtD
Sibutramine—Asthenia—Timolol—coronary artery disease	5.71e-05	0.000119	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—TGFB1—coronary artery disease	5.66e-05	0.000764	CbGpPWpGaD
Sibutramine—Nausea—Losartan—coronary artery disease	5.64e-05	0.000117	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—ALB—coronary artery disease	5.63e-05	0.000762	CbGpPWpGaD
Sibutramine—Pruritus—Timolol—coronary artery disease	5.63e-05	0.000117	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	5.61e-05	0.000758	CbGpPWpGaD
Sibutramine—Diarrhoea—Ramipril—coronary artery disease	5.57e-05	0.000116	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	5.45e-05	0.000737	CbGpPWpGaD
Sibutramine—Diarrhoea—Timolol—coronary artery disease	5.44e-05	0.000113	CcSEcCtD
Sibutramine—Hypersensitivity—Lisinopril—coronary artery disease	5.44e-05	0.000113	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	5.42e-05	0.000733	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PLAT—coronary artery disease	5.38e-05	0.000728	CbGpPWpGaD
Sibutramine—Dizziness—Ramipril—coronary artery disease	5.38e-05	0.000112	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	5.31e-05	0.000718	CbGpPWpGaD
Sibutramine—Asthenia—Lisinopril—coronary artery disease	5.29e-05	0.00011	CcSEcCtD
Sibutramine—Dizziness—Timolol—coronary artery disease	5.26e-05	0.00011	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	5.24e-05	0.000708	CbGpPWpGaD
Sibutramine—Pruritus—Lisinopril—coronary artery disease	5.22e-05	0.000109	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	5.18e-05	0.000701	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CREB1—coronary artery disease	5.17e-05	0.000699	CbGpPWpGaD
Sibutramine—Vomiting—Ramipril—coronary artery disease	5.17e-05	0.000108	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PLG—coronary artery disease	5.17e-05	0.000698	CbGpPWpGaD
Sibutramine—Rash—Ramipril—coronary artery disease	5.13e-05	0.000107	CcSEcCtD
Sibutramine—Dermatitis—Ramipril—coronary artery disease	5.12e-05	0.000107	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GCLC—coronary artery disease	5.12e-05	0.000693	CbGpPWpGaD
Sibutramine—Headache—Ramipril—coronary artery disease	5.1e-05	0.000106	CcSEcCtD
Sibutramine—Vomiting—Timolol—coronary artery disease	5.06e-05	0.000105	CcSEcCtD
Sibutramine—Diarrhoea—Lisinopril—coronary artery disease	5.05e-05	0.000105	CcSEcCtD
Sibutramine—Rash—Timolol—coronary artery disease	5.01e-05	0.000104	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—TGFB1—coronary artery disease	5.01e-05	0.000677	CbGpPWpGaD
Sibutramine—Dermatitis—Timolol—coronary artery disease	5.01e-05	0.000104	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—ALB—coronary artery disease	4.99e-05	0.000675	CbGpPWpGaD
Sibutramine—Headache—Timolol—coronary artery disease	4.98e-05	0.000104	CcSEcCtD
Sibutramine—Dizziness—Lisinopril—coronary artery disease	4.88e-05	0.000102	CcSEcCtD
Sibutramine—Nausea—Ramipril—coronary artery disease	4.83e-05	0.000101	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.77e-05	0.000645	CbGpPWpGaD
Sibutramine—Nausea—Timolol—coronary artery disease	4.72e-05	9.84e-05	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—coronary artery disease	4.7e-05	0.000635	CbGpPWpGaD
Sibutramine—Vomiting—Lisinopril—coronary artery disease	4.69e-05	9.77e-05	CcSEcCtD
Sibutramine—Rash—Lisinopril—coronary artery disease	4.65e-05	9.69e-05	CcSEcCtD
Sibutramine—Dermatitis—Lisinopril—coronary artery disease	4.65e-05	9.68e-05	CcSEcCtD
Sibutramine—Headache—Lisinopril—coronary artery disease	4.62e-05	9.63e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PLG—coronary artery disease	4.58e-05	0.000619	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—APOB—coronary artery disease	4.57e-05	0.000617	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	4.39e-05	0.000594	CbGpPWpGaD
Sibutramine—Nausea—Lisinopril—coronary artery disease	4.38e-05	9.13e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.22e-05	0.000571	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—APOB—coronary artery disease	4.05e-05	0.000547	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GGT1—coronary artery disease	4e-05	0.000541	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—coronary artery disease	3.84e-05	0.000519	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.82e-05	0.000516	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA5B—coronary artery disease	3.63e-05	0.000491	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.61e-05	0.000489	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	3.59e-05	0.000486	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	3.54e-05	0.000479	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	3.3e-05	0.000446	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	3.26e-05	0.00044	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.2e-05	0.000433	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CKMT1B—coronary artery disease	3.09e-05	0.000418	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—MAPK1—coronary artery disease	2.93e-05	0.000396	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.86e-05	0.000387	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ALB—coronary artery disease	2.54e-05	0.000343	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.52e-05	0.00034	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.52e-05	0.00034	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CKM—coronary artery disease	2.52e-05	0.00034	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SULT4A1—coronary artery disease	2.34e-05	0.000316	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	2.34e-05	0.000316	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PYGM—coronary artery disease	2.34e-05	0.000316	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PDK4—coronary artery disease	2.34e-05	0.000316	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CKMT2—coronary artery disease	2.34e-05	0.000316	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—POMC—coronary artery disease	2.33e-05	0.000315	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LDHA—coronary artery disease	2.09e-05	0.000282	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GYG1—coronary artery disease	2.09e-05	0.000282	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.09e-05	0.000282	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GK—coronary artery disease	2.09e-05	0.000282	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PFKM—coronary artery disease	2.09e-05	0.000282	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GATM—coronary artery disease	2.09e-05	0.000282	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GCH1—coronary artery disease	1.99e-05	0.000269	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AK1—coronary artery disease	1.99e-05	0.000269	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MDH2—coronary artery disease	1.91e-05	0.000258	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.91e-05	0.000258	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPAT—coronary artery disease	1.91e-05	0.000258	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UGCG—coronary artery disease	1.91e-05	0.000258	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PGM1—coronary artery disease	1.84e-05	0.000248	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CKB—coronary artery disease	1.77e-05	0.00024	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PYGB—coronary artery disease	1.77e-05	0.00024	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.67e-05	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DLAT—coronary artery disease	1.67e-05	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.67e-05	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—COX5B—coronary artery disease	1.67e-05	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.67e-05	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.58e-05	0.000214	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.51e-05	0.000204	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HK2—coronary artery disease	1.51e-05	0.000204	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.45e-05	0.000195	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.42e-05	0.000192	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LCAT—coronary artery disease	1.42e-05	0.000192	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOA4—coronary artery disease	1.39e-05	0.000188	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.34e-05	0.000182	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GCLM—coronary artery disease	1.34e-05	0.000182	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.3e-05	0.000176	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.3e-05	0.000176	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.28e-05	0.000173	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.26e-05	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HADH—coronary artery disease	1.26e-05	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.2e-05	0.000162	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOA2—coronary artery disease	1.2e-05	0.000162	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPX2—coronary artery disease	1.2e-05	0.000162	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.18e-05	0.00016	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.18e-05	0.00016	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HK1—coronary artery disease	1.18e-05	0.00016	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPX4—coronary artery disease	1.18e-05	0.00016	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HADHA—coronary artery disease	1.17e-05	0.000158	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.16e-05	0.000156	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LPA—coronary artery disease	1.14e-05	0.000155	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.11e-05	0.00015	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOA5—coronary artery disease	1.1e-05	0.000148	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—P4HB—coronary artery disease	1.07e-05	0.000145	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.06e-05	0.000143	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—VCAN—coronary artery disease	9.95e-06	0.000134	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDOA—coronary artery disease	9.87e-06	0.000133	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DCN—coronary artery disease	9.58e-06	0.000129	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDH2—coronary artery disease	9.32e-06	0.000126	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LIPC—coronary artery disease	9.08e-06	0.000123	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HBA1—coronary artery disease	9.08e-06	0.000123	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	9.08e-06	0.000123	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	9.08e-06	0.000123	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOC3—coronary artery disease	9.03e-06	0.000122	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LDLR—coronary artery disease	8.97e-06	0.000121	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTT1—coronary artery disease	8.86e-06	0.00012	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	8.86e-06	0.00012	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GCLC—coronary artery disease	8.76e-06	0.000118	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CETP—coronary artery disease	8.76e-06	0.000118	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SDC1—coronary artery disease	8.66e-06	0.000117	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PSMA6—coronary artery disease	8.19e-06	0.000111	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PSMB5—coronary artery disease	8.19e-06	0.000111	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CTGF—coronary artery disease	8e-06	0.000108	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMGCR—coronary artery disease	7.92e-06	0.000107	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GOT2—coronary artery disease	7.92e-06	0.000107	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLCB1—coronary artery disease	7.29e-06	9.85e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCA1—coronary artery disease	7.06e-06	9.55e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GOT1—coronary artery disease	6.84e-06	9.25e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GGT1—coronary artery disease	6.84e-06	9.25e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.14e-06	8.31e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.09e-06	8.23e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.06e-06	8.19e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CAT—coronary artery disease	5.98e-06	8.08e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOB—coronary artery disease	5.8e-06	7.85e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.65e-06	7.63e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LPL—coronary artery disease	5.54e-06	7.49e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPX1—coronary artery disease	5.41e-06	7.31e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CD36—coronary artery disease	5.27e-06	7.12e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.2e-06	7.03e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.99e-06	6.75e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AGT—coronary artery disease	4.74e-06	6.41e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOE—coronary artery disease	4.65e-06	6.28e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOA1—coronary artery disease	4.59e-06	6.21e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARG—coronary artery disease	4.05e-06	5.47e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—POMC—coronary artery disease	3.99e-06	5.39e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALB—coronary artery disease	3.64e-06	4.92e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NOS3—coronary artery disease	3.48e-06	4.7e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.18e-06	4.3e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.96e-06	2.65e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKT1—coronary artery disease	1.6e-06	2.16e-05	CbGpPWpGaD
